title: The THUNDER trial results: clearing the way or ushering the storm?
authors.affiliation: Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: mjaff@partners.org.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Jaff
mesh_terms: D000800:Angioplasty, Balloon / Q000295:instrumentation*; D002317:Cardiovascular Agents / Q000008:administration & dosage*; D020099:Coated Materials, Biocompatible; D005260:Female; D005263:Femoral Artery; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000008:administration & dosage*; D058729:Peripheral Arterial Disease / Q000628:therapy*; D011150:Popliteal Artery; D062666:Vascular Access Devices
chemical_list: D002317:Cardiovascular Agents; D020099:Coated Materials, Biocompatible; D017239:Paclitaxel
keywords: drug coated balloons; peripheral artery disease; restenosis